Remodulin Logo
Remodulin Logo
PI

REVEAL 2.0 Risk Assessment1

The REVEAL 2.0 Risk Calculator1:
Patients within the REVEAL study were grouped by their REVEAL 2.0 baseline risk score and their estimated 1-year prognosis

Interpretation

Emily has a very poor prognosis at baseline as assessed by REVEAL 2.0